Sign in

NCT04002141CompletedPhase 2

Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis

Source: ClinicalTrials.gov · Last updated 28 Jan 2026

Brief summary (registry, in English)

Randomized double blinded placebo-controlled trial to evaluate the impact of ovarian hyperstimulation on endometriosis-related symptoms and to evaluate the impact of letrozole use during ovarian hyperstimulation with respect to endometriosis-related symptoms, embryo/egg quality and quantity, and pregnancy rates.

Status (registry)
Completed
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
60 (actual)
First submitted
28 May 2019
Start date
17 Sept 2019
Primary completion date
1 Oct 2023
Lead sponsor
University of California, San Francisco
NCT number
NCT04002141

What you commit to

  • Study type: Interventional · Phase 2
  • Participants enrolled: 60
  • From 17 Sept 2019 to the primary completion date, 1 Oct 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Any significant concurrent disease, illness, or psychiatric disorder that would compromise patient safety or compliance, interfere with consent, study participation, follow-up, or interpretation of study results

Other illness

  • Hypersensitivity to letrozole

Who the study is looking for

  • Age 18-42 years
  • Planning to undergo controlled ovarian hyperstimulation
  • Prior diagnosis of endometriosis by one of the following: (1) surgical diagnosis (2) endometrioma on pelvic ultrasound
  • Planning to freeze all retrieved oocytes/embryos prior to transfer

Age in the registry: 18 years to 42 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UCSF Center for Reproductive Health
Coordinator of this site? Confirm its status
San FranciscoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.